HAMP and metabolic dysfunction-associated steatotic liver disease: Tsutsumi et al. reported a significant negative correlation between hepcidin immunoreactivity and fibrosis grade in pediatric population with MASLD, indicating the reduction in hepcidin in response to increased iron levels as a potential mechanism leading to liver fibrosis [155].